Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00265876. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00004190. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov study NCT00006459. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI
ClinicalTrials.gov study NCT03693677. IPD Sharing: NO. Countries: 2. Publications: 0.
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT01352494. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
ClinicalTrials.gov study NCT00743379. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03364530. IPD Sharing: NO. Countries: 1. Publications: 0.
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00006007. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT01550848. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
ClinicalTrials.gov study NCT00006224. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
ClinicalTrials.gov study NCT00262769. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04799249. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOV
ClinicalTrials.gov study NCT01971281. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
ClinicalTrials.gov study NCT01165905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
ClinicalTrials.gov study NCT00300950. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT00006462. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00922896. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT00515866. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00003358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
ClinicalTrials.gov study NCT02621151. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.